Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III and IV Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03620019
What this trial is testing

Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma

Who this might be right for
Melanoma Stage IiiMelanoma Stage IvMelanoma+2 more
UNC Lineberger Comprehensive Cancer Center 25
Early research (Phase 1)Study completedNCT02935790
What this trial is testing

Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab

Who this might be right for
Malignant Melanoma
Celgene 1
Early research (Phase 1)UnknownNCT04197882
What this trial is testing

Clinical Study to Evaluate OrienX010 in Combination With Toripalimab as Neoadjuvant Treatment in Advanced Melanoma

Who this might be right for
Melanoma
Peking University Cancer Hospital & Institute 33
Early research (Phase 1)Study completedNCT00091143
What this trial is testing

Fludarabine Followed by Vaccine Therapy and White Blood Cell Infusions in Treating Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Providence Cancer Center, Earle A. Chiles Research Institute 20
Testing effectiveness (Phase 2)Study completedNCT00002535
What this trial is testing

Indomethacin Plus Biological Therapy in Treating Patients With Advanced Melanoma

Who this might be right for
Melanoma (Skin)
St. Luke's Medical Center
Early research (Phase 1)Study completedNCT00453050
What this trial is testing

Imiquimod and Laser Therapy With or Without a Green Dye in Treating Patients With Stage III or Stage IV Melanoma That Has Spread to Other Parts of the Skin

Who this might be right for
Melanoma (Skin)Metastatic Cancer
University of Oklahoma 11
Early research (Phase 1)Study completedNCT00034554
What this trial is testing

Study of gp75 Vaccine in Patients With Stage III and IV Melanoma

Who this might be right for
Malignant Melanoma
Eli Lilly and Company 31
Not applicableLooking for participantsNCT05527795
What this trial is testing

Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma

Who this might be right for
Melanoma
Hospices Civils de Lyon 1,000
Testing effectiveness (Phase 2)UnknownNCT00489944
What this trial is testing

Sunitinib, Tamoxifen, and Cisplatin in Treating Patients With High-Risk Ocular Melanoma

Who this might be right for
Intraocular Melanoma
San Diego Pacific Oncology & Hematology Associates 50
Large-scale testing (Phase 3)Looking for participantsNCT06624644
What this trial is testing

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Who this might be right for
Melanoma (Skin Cancer)Melanoma Stage IIIB-IVCutaneous Melanoma+1 more
Linnaeus Therapeutics, Inc. 135
Testing effectiveness (Phase 2)UnknownNCT00010309
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Stage II, Stage III, or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)Study completedNCT00289016
What this trial is testing

Talimogene Laherparepvec in Stage IIIc and Stage IV Malignant Melanoma

Who this might be right for
Melanoma
BioVex Limited 50
Testing effectiveness (Phase 2)Ended earlyNCT03241927
What this trial is testing

Pembrolizumab Effects on NK Cell Exhaustion in Melanoma (Merck NK-IIT)

Who this might be right for
Melanoma
Nina Bhardwaj 1
Early research (Phase 1)Study completedNCT00217542
What this trial is testing

Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaRecurrent Renal Cell CancerStage III Melanoma+2 more
National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Ended earlyNCT02203604
What this trial is testing

High-Dose Aldesleukin and Ipilimumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+2 more
CINJRegulatory 9
Testing effectiveness (Phase 2)Looking for participantsNCT06651151
What this trial is testing

NeoLIPA: Neoadjuvant LTX-315 in Combination with Pembrolizumab in Resectable Stage III/IV Melanoma

Who this might be right for
Melanoma Stage IIIB-IV
Oslo University Hospital 27
Testing effectiveness (Phase 2)Study completedNCT01227551
What this trial is testing

Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )

Who this might be right for
Malignant Melanoma
Viralytics 57
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07740941
What this trial is testing

NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma

Who this might be right for
Melanoma (Skin Cancer)Melanoma Stage Stage IIIBMelanoma Stage M1+1 more
UNC Lineberger Comprehensive Cancer Center 55
Very early researchStudy completedNCT03655756
What this trial is testing

PDNA Intralesional Cancer Vaccine for Cutaneous Melanoma

Who this might be right for
Cutaneous Melanoma, Stage IIICutaneous Melanoma, Stage IV
TuHURA Biosciences, Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00412828
What this trial is testing

A Phase I/II Study of CR011-vcMMAE in Subjects With Unresectable Stage III or Stage IV Melanoma

Who this might be right for
Unresectable Stage III or Stage IV Melanoma
CuraGen Corporation 117
Next Page